Matthew T Campbell (Erick Campbell)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Top Venues

Nature communications

Nature medicine

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jamaal C Jackson, Darren Sanchez, Andrew C Johns, Matthew T Campbell, Ahmet Murat Aydin, Neriman Gokden, Sanjay Maraboyina, Jason L Muesse, John F Ward, Louis L Pisters, Niki M Zacharias, Charles C Guo, Shi-Ming Tu
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. Journal of clinical medicine 13 (12) (2024)
Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Jamaal C Jackson, Darren Sanchez, Andrew C Johns, Matthew T Campbell, Ahmet Murat Aydin, Neriman Gokden, Sanjay Maraboyina, Jason L Muesse, John F Ward, Louis L Pisters, Niki M Zacharias, Charles C Guo, Shi-Ming Tu
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. Journal of clinical medicine 13 (12) (2024)
Stefan Maksimovic, Nina C Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Emanuela Gentile, Pedro I Pesquera, Wenjiao Li, Jianfeng Chen, Javier A Gomez, Akshay V Basi, Jared K Burks, Christopher Alvarez-Breckenridge, Jianjun Gao, Matthew T Campbell, Eleonora Dondossola
Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone. Cancer research communications (2024)
Mohammad Jad Moussa, Matthew T Campbell, Omar Alhalabi
Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand? Biomedicines 12 (3) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Mohammad Jad Moussa, Matthew T Campbell, Omar Alhalabi
Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand? Biomedicines 12 (3) (2024)
Jose Antonio Karam, Pavlos Msaouel, Cara L Haymaker, Surena F Matin, Matthew T Campbell, Amado J Zurita, Amishi Yogesh Shah, Ignacio I Wistuba, Enrica Marmonti, Dzifa Y Duose, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Caddie Laberiano Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M Tannir, Christopher G Wood
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nature communications 14 (1) (2023)
Jose Antonio Karam, Pavlos Msaouel, Cara L Haymaker, Surena F Matin, Matthew T Campbell, Amado J Zurita, Amishi Yogesh Shah, Ignacio I Wistuba, Enrica Marmonti, Dzifa Y Duose, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Caddie Laberiano Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M Tannir, Christopher G Wood
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nature communications 14 (1) (2023)
Matthew T Campbell, Tian Zhang
Special Issue Editorial: Emerging Therapies in Renal Cell Carcinoma: The Road to a Cure? Cancers 15 (21) (2023)
Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason Alexander Efstathiou, Petros D Grivas, Shilpa Gupta, Neil J Kurtz, Donald Lamm, Seth P Lerner, Roger Li, David J McConkey, Joan Palou Redorta, Thomas Powles, Sarah P Psutka, Neal D Shore, Gary D Steinberg, Richard Sylvester, J Alfred Witjes, Matthew D Galsky
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jose Antonio Karam, Pavlos Msaouel, Cara L Haymaker, Surena F Matin, Matthew T Campbell, Amado J Zurita, Amishi Yogesh Shah, Ignacio I Wistuba, Enrica Marmonti, Dzifa Y Duose, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Caddie Laberiano Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M Tannir, Christopher G Wood
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nature communications 14 (1) (2023)
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, Xuemei Wang, Ying Yuan, Eric Jonasch, Jianjun Gao, Matthew T Campbell, Amishi Yogesh Shah, Paul Gettys Corn, Alda L Tam, Kamran Ahrar, Priya Rao, Kanishka Sircar, Lorenzo Cohen, Sreyashi Basu, Fei Duan, Sonali Jindal, Yuwei Zhang, Hong Chen, Shalini Singh Yadav, Ronald Shazer, Hirak Der-Torossian, James P Allison, Padmanee Sharma, Nizar M Tannir
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Science translational medicine 14 (641) (2022)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 13 (1) (2022)
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, Yang Lu, Qi Wang, Sumankalai Ramachandran, Rebecca S Slack Tidwell, Guangchun Han, Xinmiao Yan, Jieru Meng, Ruiping Wang, Anh G Hoang, Wei-Lien Wang, Jian Song, Lidia Lopez, Alex Andreev-Drakhlin, Arlene O Siefker-Radtke, Xinqiao Zhang, William F Benedict, Amishi Yogesh Shah, Jennifer Wang, Pavlos Msaouel, Miao Zhang, Charles C Guo, Bogdan Czerniak, Carmen Behrens, Luisa Maren Solis Soto, Vassiliki Papadimitrakopoulou, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jiun-Kae Jack Lee, Jack A Roth, Stephen G Swisher, Ignacio Wistuba, John Victor Heymach, Jing Wang, Matthew T Campbell, Eleni Efstathiou, Mark Titus, Christopher L Logothetis, Thai H Ho, Jianjun Zhang, Linghua Wang, Jianjun Gao
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nature communications 13 (1) (2022)
Matthew T Campbell, Surena F Matin, Alda L Tam, Rahul A Sheth, Kamran Ahrar, Rebecca S Slack Tidwell, Priya Rao, Jose Antonio Karam, Christopher G Wood, Nizar M Tannir, Eric Jonasch, Jianjun Gao, Amado J Zurita, Amishi Yogesh Shah, Sonali Jindal, Fei Duan, Sreyashi Basu, Hong Chen, Alexsandra B Espejo, James P Allison, Shalini S Yadav, Padmanee Sharma
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nature communications 12 (1) (2021)
Mary E Westerman, Daniel D Shapiro, Nizar M Tannir, Matthew T Campbell, Surena F Matin, Jose Antonio Karam, Christopher G Wood
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models. BJU international 126 (6) (2020)
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, Alexander Y Andreev-Drakhlin, Funda Meric-Bernstam, Aung Naing, Sarina Piha-Paul, Filip Janku, Shubham Pant, Timothy Anthony Yap, David S Hong, Siqing Fu, Daniel Karp, Matthew T Campbell, Hung Le, Amishi Y Shah, Nizar M Tannir, Arlene O Siefker-Radtke, Jianjun Gao, Jason Roszik, Vivek Subbiah
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes. Molecular cancer research : MCR 19 (3) (2020)
Robert J Motzer, Paul B Robbins, Thomas Powles, Laurence Albiges, John B A G Haanen, James Larkin, Xinmeng Jasmine Mu, Keith A Ching, Motohide Uemura, Sumanta K Pal, Boris Alekseev, Gwenaelle Gravis, Matthew T Campbell, Konstantin Penkov, Jae Lyun Lee, Subramanian Hariharan, Xiao Wang, Weidong Zhang, Jing Wang, Aleksander Chudnovsky, Alessandra di Pietro, Amber C Donahue, Toni K Choueiri
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nature medicine 26 (11) (2020)
Jianjun Gao, Neema Navai, Omar Alhalabi, Arlene Siefker-Radtke, Matthew T Campbell, Rebecca S Slack Tidwell, Charles C Guo, Ashish M Kamat, Surena F Matin, John C Araujo, Amishi Y Shah, Pavlos Msaouel, Paul Corn, Jianbo Wang, John N Papadopoulos, Shalini S Yadav, Jorge M Blando, Fei Duan, Sreyashi Basu, Wenbin Liu, Yu Shen, Yuwei Zhang, Marc Daniel Macaluso, Ying Wang, Jianfeng Chen, Jianhua Zhang, P Andrew Futreal, Colin Dinney, James P Allison, Sangeeta Goswami, Padmanee Sharma
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nature medicine 26 (12) (2020)
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, Vancheswaran Gopalakrishnan, Kati Choi, Hebert L DuPont, Zhi-Dong Jiang, Hamzah Abu-Sbeih, Christopher A Sanchez, Chia-Chi Chang, Edwin R Parra, Alejandro Francisco-Cruz, Gottumukkala S Raju, John R Stroehlein, Matthew T Campbell, Jianjun Gao, Sumit K Subudhi, Dipen M Maru, Jorge M Blando, Alexander J Lazar, James P Allison, Padmanee Sharma, Michael T Tetzlaff, Jennifer A Wargo, Robert R Jenq
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nature medicine 24 (12) (2018)